Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

Prostate cancer screening breakthrough could cut time of test to twenty minutes - One in eight men will be diagnosed with ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

Vir Biotechnology shares were up 67% to $13.15 after the company reported encouraging initial Phase 1 data for its dual-masked T-cell engagers, VIR-5818 and VIR-5500. The clinical-stage ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...